Search filters

List of works by Apostolia Maria Tsimberidou

A decision support framework for genomically informed investigational cancer therapy

scientific article

A nonparametric Bayesian basket trial design

scientific article published on 28 May 2018

A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver

scientific article

A phase I clinical trial of darinaparsin in patients with refractory solid tumors.

scientific article published on 7 July 2009

A phase I clinical trial of hepatic arterial infusion of oxaliplatin and oral capecitabine, with or without intravenous bevacizumab, in patients with advanced cancer and predominant liver involvement

scientific article published on 04 September 2018

A phase I study of fludarabine, cytarabine, and oxaliplatin therapy in patients with relapsed or refractory acute myeloid leukemia

scientific article

A phase I study of hepatic arterial infusion of nab-paclitaxel in combination with intravenous gemcitabine and bevacizumab for patients with advanced cancers and predominant liver metastases

scientific article

A phase I trial of combination trastuzumab, lapatinib, and bevacizumab in patients with advanced cancer

scientific article

A pilot study of temsirolimus and body composition

scientific article published on 27 July 2013

Aberrations in the epidermal growth factor receptor gene in 958 patients with diverse advanced tumors: implications for therapy.

scientific article

Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies

scientific article published in May 2015

Activity of interferon-alpha and isotretinoin in patients with advanced, refractory lymphoid malignancies

scientific article

Adaptive randomized study of idarubicin and cytarabine alone or with interleukin-11 as induction therapy in patients aged 50 or above with acute myeloid leukemia or high-risk myelodysplastic syndromes

scientific article

Advance care planning in patients with cancer referred to a phase I clinical trials program: the MD Anderson Cancer Center experience

scientific article published on 9 July 2012

Advanced gynecologic malignancies treated with a combination of the VEGF inhibitor bevacizumab and the mTOR inhibitor temsirolimus

scientific article

Advanced malignancies treated with a combination of the VEGF inhibitor bevacizumab, anti-EGFR antibody cetuximab, and the mTOR inhibitor temsirolimus

scientific article published on 24 February 2016

Anagrelide and imatinib mesylate combination therapy in patients with chronic myeloproliferative disorders

scientific article

Analysis of 1,115 patients tested for MET amplification and therapy response in the MD Anderson Phase I Clinic.

scientific article published on 17 October 2014

Anaplastic large cell lymphoma with involvement of the pancreas presenting as panniculitis in a patient with a history of acute myeloid leukemia--case report and review of the literature.

scientific article published on December 2006

Anastrozole and everolimus in advanced gynecologic and breast malignancies: activity and molecular alterations in the PI3K/AKT/mTOR pathway

scientific article

Anti-B4 blocked ricin post chemotherapy in patients with chronic lymphocytic leukemia--long-term follow-up of a monoclonal antibody-based approach to residual disease

scientific article published on 01 October 2003

Anti-vascular endothelial growth factor therapies and cardiovascular toxicity: what are the important clinical markers to target?

scientific article published on 05 February 2010

Anti-vascular endothelial growth factor therapy in the era of personalized medicine

scientific article published on 06 March 2013

Antiangiogenesis and gene aberration-related therapy may improve overall survival in patients with concurrent KRAS and TP53 hotspot mutant cancer

scientific article

Antibody-independent isolation of circulating tumor cells by continuous-flow dielectrophoresis.

scientific article published on 16 January 2013

Antitumor Response to Combined Antiangiogenic and Cytotoxic Chemotherapy in Recurrent Metastatic Chromophobe Renal Cell Carcinoma: Response Signatures and Proteomic Correlates

scientific article published on 11 November 2015

Assessing PIK3CA and PTEN in early-phase trials with PI3K/AKT/mTOR inhibitors

scientific article published on 16 January 2014

Assessment of chronic lymphocytic leukemia and small lymphocytic lymphoma by absolute lymphocyte counts in 2,126 patients: 20 years of experience at the University of Texas M.D. Anderson Cancer Center

scientific article published in October 2007

Authors' Reply.

scientific article published in January 2018

Autoimmune Granulomatous Inflammation of Lacrimal Glands and Axonal Neuritis Following Treatment With Ipilimumab and Radiation Therapy

scholarly article by Ecaterina Ileana Dumbrava et al published September 2018 in Journal of Immunotherapy

BRAF Mutation Testing in Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using a Rapid, Automated Molecular Diagnostics System

scientific article published on 20 May 2016

BRAF mutation testing with a rapid, fully integrated molecular diagnostics system

scientific article

BRAF mutations in advanced cancers: clinical characteristics and outcomes

scientific article (publication date: 2011)

Barriers to study enrollment in patients with advanced cancer referred to a phase I clinical trials unit

scientific article published on 23 October 2013

Biomarker-directed therapy of squamous carcinomas of the head and neck: targeting PI3K/PTEN/mTOR pathway.

scientific article

Body composition and survival in the early clinical trials setting.

scientific article published on 15 July 2013

Cancer Therapy Directed by Comprehensive Genomic Profiling: A Single Center Study.

scientific article published on 18 May 2016

Cardiovascular toxicity profiles of vascular-disrupting agents

scientific article published on 8 July 2011

Characteristics and outcomes for patients with advanced vaginal or vulvar cancer referred to a phase I clinical trials program: the MD Anderson cancer center experience

scientific article published on 14 November 2015

Characteristics and survival of patients with advanced cancer and p53 mutations

scientific article

Chemoimmunotherapy may overcome the adverse prognostic significance of 11q deletion in previously untreated patients with chronic lymphocytic leukemia

scientific article

Chronic myeloid leukemia in a patient with acquired immune deficiency syndrome: complete cytogenetic response with imatinib mesylate: report of a case and review of the literature

scientific article published on June 2004

Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review

scientific article published on 05 March 2018

Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.

scientific article published on 5 March 2018

Clinical Next-Generation Sequencing for Precision Oncology in Rare Cancers

scientific article published on 13 April 2018

Clinical characteristics and outcomes of pediatric oncology patients with aggressive biology enrolled in phase I clinical trials designed for adults: the university of Texas MD anderson cancer center experience

scientific article

Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: the M. D. Anderson Cancer Center experience

scientific article published on 01 July 2009

Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation

scientific article

Clinical outcomes of patients with breast cancer in a phase I clinic: the M. D. Anderson cancer center experience

scientific article published in February 2010

Combining erlotinib and cetuximab is associated with activity in patients with non-small cell lung cancer (including squamous cell carcinomas) and wild-type EGFR or resistant mutations

scientific article

Common cardiovascular medications in cancer therapeutics

scientific article published on 26 January 2011

Comparison of allogeneic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia

scientific article published in April 2003

Continuous anti-angiogenic therapy after tumor progression in patients with recurrent high-grade epithelial ovarian cancer: phase I trial experience

scientific article published on 27 April 2016

Dasatinib in chronic myeloid leukemia: a review.

scientific article published on April 2009

Detection of "PNH red cell" populations in hematological disorders using the Sephacryl Gel Test micro typing system

scientific article published on 01 December 1997

Detection of Richter's transformation of chronic lymphocytic leukemia by PET/CT.

scientific article published in August 2006

Development of a prognostic scoring system for patients with advanced cancer enrolled in immune checkpoint inhibitor phase 1 clinical trials

scientific article published on 20 February 2018

Dose-escalation study of vemurafenib with sorafenib or crizotinib in patients with BRAF-mutated advanced cancers

scientific article published on 29 October 2020

Dose-finding study of hepatic arterial infusion of irinotecan-based treatment in patients with advanced cancers metastatic to the liver

scientific article

Dose-finding study of hepatic arterial infusion of oxaliplatin-based treatment in patients with advanced solid tumors metastatic to the liver

scientific article published on 11 November 2012

Dual EGFR inhibition in combination with anti-VEGF treatment in colorectal cancer

scientific article

Dual EGFR inhibition in combination with anti-VEGF treatment: a phase I clinical trial in non-small cell lung cancer

scientific article published on January 2013

Dual antiangiogenic inhibition: a phase I dose escalation and expansion trial targeting VEGF-A and VEGFR in patients with advanced solid tumors

scientific article published on 4 November 2014

Dual inhibition of the vascular endothelial growth factor pathway: a phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumors

scientific article

Effects of patupilone on the pharmacokinetics and pharmacodynamics of warfarin in patients with advanced malignancies: a phase I clinical trial

scientific article

Electrocardiograms (ECGs) in phase I anticancer drug development: the MD Anderson Cancer Center experience with 8518 ECGs

scientific article

Epstein-Barr virus in patients with chronic lymphocytic leukemia: a pilot study

scientific article published in May 2006

Epstein-Barr virus latent membrane protein 1 mRNA is expressed in a significant proportion of patients with chronic lymphocytic leukemia

scientific article

Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies

scientific article published in September 2015

Essential thrombocythemia (ET): moving from palliation to cure

scientific article

Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved Therapies

scientific article published on 17 October 2016

Evaluation of the clinical relevance of body composition parameters in patients with cancer metastatic to the liver treated with hepatic arterial infusion chemotherapy

scientific article published on 09 January 2012

Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia.

scientific article published in February 2002

Evolving role of ribonucleoside reductase inhibitors in hematologic malignancies

scientific article

Expanded access to investigational drugs: balancing patient safety with potential therapeutic benefits.

scientific article published on 22 January 2018

Exploratory study of carboplatin plus the copper-lowering agent trientine in patients with advanced malignancies

scientific article published on 5 December 2013

Exploring response signals and targets in aggressive unresectable hepatocellular carcinoma: an analysis of targeted therapy phase 1 trials

scientific article

Extramedullary relapse in a patient with acute promyelocytic leukemia: successful treatment with arsenic trioxide, all-trans retinoic acid and gemtuzumab ozogamicin therapies

scientific article published in September 2004

FBXW7 mutations in patients with advanced cancers: clinical and molecular characteristics and outcomes with mTOR inhibitors

scientific article

Farnesyltransferase inhibitors: where are we now?

scientific article

First-in-human study of pbi-05204, an oleander-derived inhibitor of akt, fgf-2, nf-κΒ and p70s6k, in patients with advanced solid tumors.

scientific article

First-in-human trial of multikinase VEGF inhibitor regorafenib and anti-EGFR antibody cetuximab in advanced cancer patients

scientific article

Fludarabine and mitoxantrone for patients with chronic lymphocytic leukemia

scientific article published in June 2004

Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma

scientific article published on 8 August 2002

Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients wit

scientific article published in April 2003

Gemtuzumab ozogamicin, fludarabine, cytarabine and cyclosporine combination regimen in patients with CD33+ primary resistant or relapsed acute myeloid leukemia

scientific article

Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromes

scientific article published in March 2003

Gene and cell therapy for pancreatic cancer

scientific article published on 13 January 2015

Granulocyte colony stimulating factor administration associated with cerebral hemorrhage in acute promyelocytic leukemia

scientific article published on 25 May 2006

Health policy: Strategies to optimize expedited investigational new drug safety reports

scientific article published on 01 April 2016

Hepatic arterial infusion therapy in advanced cancer and liver-predominant disease: the MD Anderson Experience

scientific article published in October 2013

Hodgkin transformation of chronic lymphocytic leukemia: the M. D. Anderson Cancer Center experience

scientific article published in September 2006

Hyperuricemic syndromes in cancer patients

scientific article

Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing

scientific article

Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen

scientific article published in July 2005

Impact of microRNAs in resistance to chemotherapy and novel targeted agents in non-small cell lung cancer.

scientific article published on January 2014

Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D. Anderson Cancer Center

scientific article published on 01 April 2006

Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience

scientific article published on 21 November 2017

Induction mortality risk in adult acute myeloid leukemia

scientific article published in July 2006

Inhibition of the Ras/Raf/MEK/ERK and RET kinase pathways with the combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in medullary and differentiated thyroid malignancies

scientific article

Initiative for Molecular Profiling and Advanced Cancer Therapy and challenges in the implementation of precision medicine

scientific article published on 10 February 2017

Insurance Clearance for Early-Phase Oncology Clinical Trials Following the Affordable Care Act.

scientific article

Intraperitoneal and intravenous chemotherapy in peritoneal carcinomatosis

scientific article published on 01 June 2012

Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells

scientific article

Left ventricular ejection fraction in advanced cancer patients: a valuable prognostic tool?

scientific article

Lenalidomide in solid tumors

scientific article published on 15 May 2012

Liposomal vincristine in relapsed non-Hodgkin's lymphomas: early results of an ongoing phase II trial.

scientific article published on January 2000

Liquid Biopsies Using Plasma Exosomal Nucleic Acids and Plasma Cell-Free DNA Compared with Clinical Outcomes of Patients with Advanced Cancers

scientific article published on 19 October 2017

Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine

scientific article published on 30 December 2019

MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study

scientific article

MET nucleotide variations and amplification in advanced ovarian cancer: characteristics and outcomes with c-Met inhibitors

scientific article

Managing cardiac risk factors in oncology clinical trials ⬇️

scientific article published on January 1, 2011

Melanoma patients in a phase I clinic: molecular aberrations, targeted therapy and outcomes.

scientific article

Metastatic gastric adenocarcinoma following allogeneic stem cell transplantation in a patient with acute myelogenous leukemia

scientific article published on 01 March 2003

Mitoxantrone and prolonged infusion gemcitabine as salvage therapy in patients with acute myelogenous leukemia

scientific article published in April 2003

Multiplex KRASG12/G13 mutation testing of unamplified cell-free DNA from the plasma of patients with advanced cancers using droplet digital polymerase chain reaction

scientific article published on 19 December 2016

Mutation-Enrichment Next-Generation Sequencing for Quantitative Detection of KRAS Mutations in Urine Cell-Free DNA from Patients with Advanced Cancers

scientific article published on 17 January 2017

Myeloid sarcoma involving the gynecologic tract: a report of 11 cases and review of the literature

scientific article

Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia

scientific article published on September 2008

Mylotarg combined with topotecan and cytarabine in patients with refractory acute myelogenous leukemia

scientific article

Mylotarg, fludarabine, cytarabine (ara-C), and cyclosporine (MFAC) regimen as post-remission therapy in acute myelogenous leukemia

scientific article published on 9 September 2003

Next generation sequencing of carcinoma of unknown primary reveals novel combinatorial strategies in a heterogeneous mutational landscape

scientific article

Next generation sequencing of exceptional responders with BRAF-mutant melanoma: implications for sensitivity and resistance

scientific article

Obinutuzumab for the treatment of chronic lymphocytic leukemia and other B-cell lymphoproliferative disorders.

scientific article

Older adults in phase I clinical trials: a comparative analysis of participation and clinical benefit rate among older adults versus middle age and AYA patients on phase I clinical trials with VEGF/VEGFR inhibitors.

scientific article published on 22 June 2018

Optimizing treatment for elderly patients with acute promyelocytic leukemia: is it time to replace chemotherapy with all-trans retinoic acid and arsenic trioxide?

scientific article published on November 2006

Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma

scientific article published on 29 December 2008

Outcome analysis of Phase I trial patients with metastatic and/or mutant non-small cell lung cancer

Outcomes in 144 patients with colorectal cancer treated in a phase I clinic: the MD Anderson Cancer Center experience

scientific article published on 25 April 2012

Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone

scientific article published on 01 July 2006

Outcomes of patients with advanced cancer and KRAS mutations in phase I clinical trials

scientific article

Outcomes of patients with advanced non-small cell lung cancer treated in a phase I clinic

scientific article published on 21 February 2011

Outcomes of patients with metastatic cervical cancer in a phase I clinical trials program.

scientific article

Outcomes of patients ≥65 years old with advanced cancer treated on phase I trials at MD ANDERSON CANCER CENTER.

scientific article

Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Center experience

scientific article published on 3 August 2017

Outcomes of research biopsies in phase I clinical trials: the MD anderson cancer center experience

scientific article published on 22 August 2011

Overview of precision oncology trials: challenges and opportunities

scientific article published on 10 August 2018

P53 mutations in advanced cancers: clinical characteristics, outcomes, and correlation between progression-free survival and bevacizumab-containing therapy

scientific article published on May 2013

PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations

scientific article published on 23 January 2012

PIK3CA mutation H1047R is associated with response to PI3K/AKT/mTOR signaling pathway inhibitors in early-phase clinical trials

scientific article published on 12 October 2012

PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers

scientific article

PIK3CA mutations in advanced cancers: characteristics and outcomes

scientific article published on December 2012

PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors

scientific article

Pediatric therapy-related myelodysplastic syndrome/acute myeloid leukemia: the MD Anderson Cancer Center experience

scientific article published in November 2009

Personalized medicine for patients with advanced cancer in the phase I program at MD Anderson: validation and landmark analyses

scientific article published in July 2014

Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative

scientific article published on 10 September 2012

Pharmacokinetic evaluation of vincristine for the treatment of lymphoid malignancies

scientific article published on 10 February 2014

Pharmacokinetics and antitumor activity of patupilone combined with midazolam or omeprazole in patients with advanced cancer

scientific article

Phase 1 clinical trials in 83 patients with pancreatic cancer: The M. D. Anderson Cancer Center experience

scientific article

Phase 1 dose-escalation study of anti CTLA-4 antibody ipilimumab and lenalidomide in patients with advanced cancers

scientific article published on 13 December 2017

Phase 1 first-in-human clinical study of S-trans,trans-farnesylthiosalicylic acid (salirasib) in patients with solid tumors.

scientific article published in January 2010

Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients With BRAF-mutated melanoma and other advanced malignancies

scientific article published on 01 November 2018

Phase I clinical trial of MPC-6827 (Azixa), a microtubule destabilizing agent, in patients with advanced cancer

scientific article published on 01 December 2010

Phase I clinical trial of bendamustine and bevacizumab for patients with advanced cancer

scientific article

Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies

scientific article

Phase I clinical trial of hepatic arterial infusion of cisplatin in combination with intravenous liposomal doxorubicin in patients with advanced cancer and dominant liver involvement

scientific article

Phase I clinical trial of hepatic arterial infusion of paclitaxel in patients with advanced cancer and dominant liver involvement

scientific article

Phase I clinical trial of lenalidomide in combination with 5-fluorouracil, leucovorin, and oxaliplatin in patients with advanced cancer

scientific article

Phase I clinical trial of lenalidomide in combination with bevacizumab in patients with advanced cancer

scientific article

Phase I clinical trial of lenalidomide in combination with sorafenib in patients with advanced cancer

scientific article

Phase I clinical trial of lenalidomide in combination with temsirolimus in patients with advanced cancer

scientific article

Phase I clinical trial outcomes in 93 patients with brain metastases: the MD anderson cancer center experience

scientific article

Phase I clinical trials in 56 patients with thyroid cancer: the M. D. Anderson Cancer Center experience

scientific article published on 09 October 2009

Phase I combination of pazopanib and everolimus in PIK3CA mutation positive/PTEN loss patients with advanced solid tumors refractory to standard therapy

scientific article

Phase I dose escalation study of temsirolimus in combination with metformin in patients with advanced/refractory cancers.

scientific article

Phase I dose-escalation study of the mTOR inhibitor sirolimus and the HDAC inhibitor vorinostat in patients with advanced malignancy

scientific article

Phase I study of BIIB028, a selective heat shock protein 90 inhibitor, in patients with refractory metastatic or locally advanced solid tumors

scientific article published on 19 July 2013

Phase I study of azacitidine and oxaliplatin in patients with advanced cancers that have relapsed or are refractory to any platinum therapy

scientific article

Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours

scientific article published on 23 March 2020

Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in patients with advanced cancers

scientific article published on 26 April 2018

Phase I study of pazopanib and vorinostat: a therapeutic approach for inhibiting mutant p53-mediated angiogenesis and facilitating mutant p53 degradation.

scientific article

Phase I study of the combination of crizotinib (as a MET inhibitor) and dasatinib (as a c-SRC inhibitor) in patients with advanced cancer

scientific article published on 19 October 2017

Phase I trial of valproic acid and lenalidomide in patients with advanced cancer

scientific article

Phase I-II clinical trial of oxaliplatin, fludarabine, cytarabine, and rituximab therapy in aggressive relapsed/refractory chronic lymphocytic leukemia or Richter syndrome

scientific article

Phase I-II study of oxaliplatin, fludarabine, cytarabine, and rituximab combination therapy in patients with Richter's syndrome or fludarabine-refractory chronic lymphocytic leukemia

scientific article published in January 2008

Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAFV600E Mutation

scientific article published on 11 October 2016

Phase II study of fludarabine, cytarabine (Ara-C), cyclophosphamide, cisplatin and GM-CSF (FACPGM) in patients with Richter's syndrome or refractory lymphoproliferative disorders

scientific article

Phase II study of pentostatin in advanced T-cell lymphoid malignancies: update of an M.D. Anderson Cancer Center series

scientific article

Physiologically-based pharmacokinetic modelling to predict oprozomib CYP3A drug-drug interaction potential in patients with advanced malignancies

scientific article published on 25 December 2018

Pilot study of Mylotarg, idarubicin and cytarabine combination regimen in patients with primary resistant or relapsed acute myeloid leukemia

scientific article

Pilot study of gemtuzumab ozogamicin, liposomal daunorubicin, cytarabine and cyclosporine regimen in patients with refractory acute myelogenous leukemia

scientific article

Pilot study of recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein (TNFR:Fc; Enbrel) in patients with refractory multiple myeloma: increase in plasma TNF alpha levels during treatment

scientific article published on 01 May 2003

Post-Discharge Survival Outcomes of Patients with Advanced Cancer from the University of Texas MD Anderson Cancer Center Investigational Cancer Therapeutics (Phase I Trials) Inpatient Unit

scientific article published on 2 November 2016

Potential curability of newly diagnosed acute promyelocytic leukemia without use of chemotherapy: the example of liposomal all-trans retinoic acid

scientific article published in February 2005

Precision cancer medicine: the future is now, only better

scientific article

Precision medicine: lessons learned from the SHIVA trial

scientific article published on 01 December 2015

Predicting outcomes in patients with advanced non-small cell lung cancer enrolled in early phase immunotherapy trials.

scientific article published on 11 April 2018

Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic

Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression

scientific article published on 28 September 2010

Quantitative real-time polymerase chain reaction for detection of circulating cells with t(14;18) in volunteer blood donors and patients with follicular lymphoma

scientific article published on 01 August 2002

Quantitative real-time polymerase chain reaction for monitoring minimal residual disease in patients with advanced indolent lymphomas treated with rituximab, fludarabine, mitoxantrone, and dexamethasone

scientific article published in February 2002

Recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein Enbrel in patients with refractory hematologic malignancies

scientific article published on 26 July 2002

Relevance of clinical trials in acute myeloid leukaemia

scientific article published in September 2008

Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response

scientific article published on 16 October 2015

Revisiting clinical trials using EGFR inhibitor-based regimens in patients with advanced non-small cell lung cancer: a retrospective analysis of an MD Anderson Cancer Center phase I population

scientific article published on May 2013

Richter syndrome: biology, incidence, and therapeutic strategies

scientific article

Richter's transformation in chronic lymphocytic leukemia

scientific article published on 01 April 2006

Richter's transformation in chronic lymphocytic leukemia.

scientific article

Risk of serious toxicity in 1181 patients treated in phase I clinical trials of predominantly targeted anticancer drugs: the M. D. Anderson Cancer Center experience

scientific article

Salirasib in the treatment of pancreatic cancer

scientific article published on June 2010

Single-agent liposomal all-trans retinoic acid can cure some patients with untreated acute promyelocytic leukemia: an update of The University of Texas M. D. Anderson Cancer Center Series.

scientific article

Sleep quality and its association with fatigue, symptom burden, and mood in patients with advanced cancer in a clinic for early-phase oncology clinical trials

scientific article published on 14 July 2016

Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists

scientific article published on January 2017

Strategies to overcome clinical, regulatory, and financial challenges in the implementation of personalized medicine

scientific article published on January 2013

Survival of 1,181 patients in a phase I clinic: the MD Anderson Clinical Center for targeted therapy experience

scientific article

Survival of patients in a Phase 1 Clinic: the M. D. Anderson Cancer Center experience

scientific article

Survival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experience

scientific article

Synergy between VEGF/VEGFR inhibitors and chemotherapy agents in the phase I clinic

scientific article published on 14 October 2014

TNF-alpha targeted therapeutic approaches in patients with hematologic malignancies

scientific article

TP53 Alterations Correlate with Response to VEGF/VEGFR Inhibitors: Implications for Targeted Therapeutics

scientific article published on 27 July 2016

Target-based therapeutic matching in early-phase clinical trials in patients with advanced colorectal cancer and PIK3CA mutations

scientific article

Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experience

scientific article

Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification

scientific article published on 01 June 2018

Targeted therapy in cancer

scientific article published on 21 September 2015

Targeted therapy of advanced gallbladder cancer and cholangiocarcinoma with aggressive biology: eliciting early response signals from phase 1 trials

scientific article published on January 2013

The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who fail alemtuzumab or have bulky lymphadenopathy

scientific article published in October 2007

The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes

scientific article

The prognostic significance of left ventricular ejection fraction in patients with advanced cancer treated in phase I clinical trials.

scientific article published on January 2014

The prognostic significance of serum beta2 microglobulin levels in acute myeloid leukemia and prognostic scores predicting survival: analysis of 1,180 patients

scientific article

The role of gemtuzumab ozogamicin in acute leukaemia therapy

scientific article

Thymoma patients treated in a phase I clinic at MD Anderson Cancer Center: responses to mTOR inhibitors and molecular analyses

scientific article published on June 2013

Transient severe hyperbilirubinemia after hepatic arterial infusion of oxaliplatin in patients with liver metastases

scientific article published on 08 October 2013

Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials

scientific article

Treatment of fludarabine-refractory chronic lymphocytic leukemia

scientific article

Treatment of patients with fludarabine-refractory chronic lymphocytic leukemia: need for new treatment options

scientific article published on July 2010

Trial Reporting in Immuno-Oncology (TRIO): An American Society of Clinical Oncology-Society for Immunotherapy of Cancer Statement

scientific article published on 19 October 2018

Trial Reporting in Immuno-Oncology (TRIO): an American society of clinical oncology-society for immunotherapy of cancer statement

scholarly article by Apostolia Maria Tsimberidou et al published 19 October 2018 in Journal for Immunotherapy of Cancer

Triple-negative breast cancer patients treated at MD Anderson Cancer Center in phase I trials: improved outcomes with combination chemotherapy and targeted agents

scientific article

Ultimate fate of oncology drugs approved by the us food and drug administration without a randomized Trial

scientific article published on 13 October 2009

Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigms

scientific article

Validation of the Royal Marsden Hospital prognostic score in patients treated in the Phase I Clinical Trials Program at the MD Anderson Cancer Center

scientific article published on 5 August 2011

Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer

scientific article published on 31 March 2015

Yttrium-90 ibritumomab tiuxetan radioimmunotherapy in Richter syndrome

scientific article

Paulina is supported by:

About Paulina

Help